In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
2d
Investor's Business Daily on MSNIs Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?
Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.
HOSPITALS have been hit by a “highly infectious” winter vomiting bug which experts have warned you can catch more than once. Norovirus cases are continuing to soar with new NHS data ...
said the Drug Control Authority (DCA) agreed to give conditional approval to Spikevax, or what is commonly known as the Moderna Covid-19 vaccine.
Live your life healthier and happier with our free weekly Living Well newsletter Every minute, one million plastic bottles are bought around the world. And of the single-use plastic food and drink ...
The plot has thickened in the Justin Trudeau-Heinz ketchup controversy, as consumers with bottles that say "Product of USA" question how Canadian the popular condiment really is. Kraft Heinz took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results